Ranbaxy Metformin Product Recall (2020-02-26)
- Starting date:
- February 26, 2020
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type I
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-72455
Last updated: 2020-02-27
Summary
-
Product:
- RAN-Metformin 850 mg Tablet
- RAN-Metformin 500 mg Tablet
- RAN-Metformin 850 mg Tablet
- RAN-Metformin 500 mg Tablet
Reason
Presence of N-nitrosodimethylamine (NDMA) above or near the interim acceptable concentration limit in affected lot(s).
Depth of distribution
Wholesalers, Healthcare Establishments, Retailers
Affected products
-
RAN-Metformin 850 mg Tablet
DIN, NPN, DIN-HIM
DIN 02269058
Dosage form
Tablet
Strength
Meformin hydrochloride 850 mg
Lot or serial number
AJZ8005A
Companies
- Recalling Firm
-
Sun Pharma Canada Inc.
126 East Drive
Brampton
L6T 1C1
Ontario
CANADA
- Marketing Authorization Holder
-
Sun Pharma Canada Inc.
126 East Drive
Brampton
L6T 1C1
Ontario
CANADA
B. RAN-Metformin 500 mg Tablet
DIN, NPN, DIN-HIM
DIN 02269031
Dosage form
Tablet
Strength
Meformin hydrochloride 500 mg
Lot or serial number
AJY8006A, AJY8007A, AJY8005A, AJY8005B, AJY8008A
Companies
- Recalling Firm
-
Sun Pharma Canada Inc.
126 East Drive
Brampton
L6T 1C1
Ontario
CANADA
- Marketing Authorization Holder
-
Sun Pharma Canada Inc.
126 East Drive
Brampton
L6T 1C1
Ontario
CANADA